Global Pharyngoconjunctival Fever Market, By Causes (Fever, Pharyngitis, Acute Follicular Conjunctivitis, Regional Lymphoid Hyperplasia with Tender, Enlarged Preauricular Adenopathy), Treatment (Cold Compresses, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.
Pharyngoconjunctival Fever Market Analysis and Size
Pharyngoconjunctival fever, a condition that is caused by a virus, is very contagious, mainly during the first few days. After 10 or 15 days, the communicability is almost zero. People who have this condition complain of fatigue and upset stomach. Children between the age group of 5 and 18 years are most vulnerable to the condition. It is often spread by children who are swimming in public swimming pools.
Data Bridge Market Research analyses a growth rate in the pharyngoconjunctival fever market in the forecast period 2023-2030. The expected CAGR of pharyngoconjunctival fever market is tend to be around 6.70% in the mentioned forecast period. The market was valued at USD 8.92 billion in 2022, and it would grow upto USD 15 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Pharyngoconjunctival Fever Market Scope and Segmentation
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customizable to 2015 - 2020) |
Quantitative Units |
Revenue in USD Billion, Volumes in Units, Pricing in USD |
Segments Covered |
Causes (Fever, Pharyngitis, Acute Follicular Conjunctivitis, Regional Lymphoid Hyperplasia with Tender, Enlarged Preauricular Adenopathy), Treatment (Cold Compresses, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
Market Players Covered |
Bausch Health Companies Inc. (Canada.), Merck & Co. Inc. (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Novartis AG (Switzerland), AstraZeneca (U.K.), Lilly (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), GSK plc (U.K.), Hikma Pharmaceuticals PLC (U.K.), Cipla Inc. (India), Lupin (India), Boehringer Ingelheim International GmbH. (Germany), Ipsen Pharma (France), ABIOGEN PHARMA SpA (Italy), Zimmer Biomet (U.S.), Ampio Pharmaceuticals Inc., eneron Pharmaceuticals Inc (U.S.), Astellas Pharma Inc. (Japan)., DAIICHI SANKYO COMPANY, LIMITED (Japan), and Endo International Inc. (Ireland) |
Market Opportunities |
|
Market Definition
Pharyngoconjunctival fever (PCF) is an acute and highly infectious illness characterized by acute follicular conjunctivitis, pharyngitis, fever, and regional lymphoid hyperplasia with tender, enlarged preauricular adenopathy. Pharyngoconjunctival fever (PCF) is often witnessed in school children because they are in close quarters. Eye complaints and symptoms generally appear within 48 hours of onset.
Pharyngoconjunctival Fever Market Dynamics
Drivers
- Rising Demand for Diagnostic Tests
Several diagnostic tests are available for the diseased condition. Diagnostic tests such as monoclonal antibody-based solid-phase immunoassay (ELISA). Ocular examination is also used to test the different parameters for this diseased condition.
Opportunities
- Increasing Treatment Options
There are varied treatment options that are available for treating these patients. Most treatment options include the use of artificial tears. Patients are recommended to use the drops 4-8 times per day for a few weeks. Optometrists and ophthalmologists also recommend a vasoconstrictor or antihistamine eye drop usually described as a “get-the-red-out” drop. Antibiotic eye drops are advised to avoid worsening of symptoms
- Increasing Demand for Retail Pharmacies
The increase in the number of pharyngoconjunctival fever therapeutics which is delivered through retail pharmacies and the increase in the number of retail pharmacies in developed countries create opportunities for the market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily available.
Restraints/Challenges
- Risk of Side-Effects
The associated side effects of the application of pharyngoconjunctival fever drugs impedes the market growth. Severe side-effects such as eye pain, continued eye redness/irritation, change in vision, and severe side effects such as allergy hampers the market growth.
This pharyngoconjunctival fever market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the pharyngoconjunctival fever market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Global Pharyngoconjunctival Fever Market Scope
The pharyngoconjunctival fever market is segmented on the basis of causes, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Causes
- Fever
- Pharyngitis
- Acute Follicular Conjunctivitis
- Regional Lymphoid Hyperplasia with Tender
- Enlarged Preauricular Adenopathy
Treatment
- Cold Compresses
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Pharyngoconjunctival Fever Market Regional Analysis/Insights
The pharyngoconjunctival fever market is analyzed and market size insights and trends are provided by causes, treatment , distribution channel and end-user as referenced above.
The major countries covered in the pharyngoconjunctival fever market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for pharyngoconjunctival fever market throughout the forecasted period due to huge patient population, and rise in the presence of huge opportunities in the market in this region.
North America dominates the market due to changing lifestyle and increase in the healthcare expenditure rise in the availability of funds for research, huge patient population, increase in the healthcare expenditures, well-developed healthcare sector and rise in the government support for research & development in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Pharyngoconjunctival Fever Market Share Analysis
The pharyngoconjunctival fever market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related pharyngoconjunctival fever market
Key players operating in the pharyngoconjunctival fever market include:
- Bausch Health Companies Inc. (Canada)
- Merck & Co. Inc. (U.S.)
- Pfizer Inc. (U.S.),
- Teva Pharmaceutical Industries Ltd. (Israel)
- Astellas Pharma Inc. (Japan)
- Bayer AG (Germany)
- Novartis AG (Switzerland)
- AstraZeneca (U.K.)
- Lilly (U.S.)
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Mylan N.V. (U.S.)
- Merck & Co., Inc. (U.S.)
- Pfizer Inc. (U.S.)
- GSK plc (U.K.)
- Hikma Pharmaceuticals PLC (U.K.)
- Cipla Inc. (India)
- Lupin (India)
- Boehringer Ingelheim International GmbH. (Germany)
- Ipsen Pharma (France)
- ABIOGEN PHARMA SpA (Italy)
- Zimmer Biomet (U.S.)
- Reneron Pharmaceuticals Inc (U.S.)
- Astellas Pharma Inc. (Japan)
- DAIICHI SANKYO COMPANY, LIMITED (Japan)
- Endo International Inc. (Ireland)
SKU-